— Publications

Half-year Report 2018


Download
All financial reports


— Media releases


August 2, 2018

Valneva Delivers Strong IXIARO® Sales Growth and Reports Further Progress on Key R&D Programs in H1

Read more


— Financial calendar


Upcoming events
Q3 2018  Results
November 8, 2018




All dates




— Meet us

 
European Large & Midcap Event
October 8-9, Paris

Biotech made in Vienna: "From Landsteiner to global products for infectious disease control"
6th Semmering symposium
October 11-13, Vienna

World Vaccine Congress Europe
October 29-31, Lisbon


Stifel 2018 Healthcare Conference
Lyme Disease

Download brochure









    

— Our responsibility

Committed to people, protecting lives and the environment


Learn more

play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

Subscribe to our Newsletter

mail-icon-lightblue.png


Contact Investor Relations

speech-balloon-icon-white.png

Please update your browser...